A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience
- 46 Downloads
Peripheral blood is the prefered source for hematopoietic stem cells for hematopoietic stem cell transplantation. The efficiency of peripheral blood stem cell (PBSC) collection can vary among devices. In this study we aimed to compare feasibility and effectivity of apheresis procedures of the different systems. Two apheresis systems [Com.Tec (Fresenius Healthcare) and Spectra Optia (Caridian BCT)] were used in our center for the collection of PBSCs for autologous and allogeneic transplantation. We retrospectively analysed 190 apheresis procedures performed in healthy donors and patients between June 2012 and November 2014 in Department of Hematology, Dokuz Eylul University. PBSCS were collected by Fresenius cell separator (64 procedure) or Spectra Optia cell separator (126 procedure). Mobilization treatments were G-CSF (26.8%), cyclophosphamide plus G-CSF (48.4%), prelixafor plus G-CSF (14.7%), ESHAP (10%) and others. Patient and donor characteristics (age, weight, volume processed, disease, mobilization regimes) were similar in Fresenius and Spectra Optia apheresis groups. Altough both collected PBSCs efficiently, the amount of CD34+ cell in product collected by Spectra Optia device was significantly higher (p < 0.05) and product volume was lower than Fresenius Com.Tec significantly (p < 0.05). “CD34+ collection efficiency” with Spectra Optia was significantly higher than Fresenius Com.Tec (CE2: 87%, 70%, p = 0.033) regarding all procedures. High collection efficiency and low product volume may be a significant characteristic of Spectra Optia device (mean 187 mL, product CD34+ cell: 1576 µL).
KeywordsApheresis Peripheral blood stem cell Autologous transplantation Allogeneic transplantation Blood cell seperators
Professional medical writing support and editor assistance were not supported by the company.
Compliance with Ethical Standards
Conflict of interest
The author did not receive financial compensation for authoring the manuscript.
- 1.Grathwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A (2005) Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transpl 36:575–590. https://doi.org/10.1038/sj.bmt.1705104 CrossRefGoogle Scholar
- 2.Stem Cell Trialists Collaborative Group (2005) Allogeneic peripheral blood stem cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol 23:5074–5087. https://doi.org/10.1200/JCO.2005.09.020 CrossRefGoogle Scholar
- 4.Altuntaş F, Koçyigit I, Ozturk A, Kaynar L, Oztekin M, Solmaz M, Eser B, Cetin M, Unal A (2007) Comparison of the Fenwal Amicus and Fresenius Com.Tec cell separators for autologous peripheral blood progenitor cell collection. Transfus Apher Sci 36:159–167. https://doi.org/10.1016/j.transci.2006.10.008 CrossRefPubMedGoogle Scholar
- 6.Adorno G, Del Proposto G, Palombi F, Bruno A, Ballatore G, Postorino M, Tednas A, Del Poeta G, Isacchi G, Amadori S (2004) Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators. Transfus Apher Sci 30:131–136. https://doi.org/10.1016/jtransci.2003.10.007 CrossRefPubMedGoogle Scholar
- 7.Bachier C, Potter J, Potter G, Sugay R, Shaughnessy P, Chan K, Jude V, Madden R, LeMaistre C (2012) High white blood cell concentration in the peripheral blood stem cell product can induse seizures during infusion of autologous peripheral blood stem cells. Am Soc Blood Marrow Transpl 18:1055–1060. https://doi.org/10.1016/j.bbmt.2011.12.500 CrossRefGoogle Scholar
- 12.Flommersfeld S, Backchoul T, Bein G, Wachtel A, Loechelt C, Sachs UJ (2013) A single center comparison between three different apheresis systems for autologous and allogenei stem cell collection. Transfus Apher Sci 49:428–433. https://doi.org/10.1016/jtransci.2013.06.002 CrossRefPubMedGoogle Scholar
- 14.Brauninger S, Bialleck H, Thorausch K, Felt T, Seifried E, Bonig H (2011) Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v. 5.0, a novel, automatic interface—controlled apheresis system: results from the first feasibility trial. Vox Sang 101:237–246. https://doi.org/10.1111/j.1423.0410.2011.01484 CrossRefPubMedGoogle Scholar
- 20.Schots R, Van Riet I, Damiaens S, Flament J, Lacor P, Staelens Y et al (1996) The absolute number of circulating CD34 cells predicts the number of hematopoetic stem cells than can be predict by apheresis. Bone Marrow Transpl 17:509–515Google Scholar